| Non-Small Cell Lung Cancer |
1 |
1 |
| Lung Cancer |
0 |
0.9 |
| Cancer |
0 |
0.6 |
| Small Cell Lung Cancer |
0 |
0.57 |
| Biologic Therapy |
0 |
0.54 |
| Toxicology |
0 |
0.48 |
| Lung |
0 |
0.45 |
| COVID-19 |
0 |
0.43 |
| Dentistry and Oral Health |
0 |
0.43 |
| Acute Pain |
0 |
0.34 |
| Thromboembolism |
0 |
0.27 |
| Tyrosine Kinase Inhibitor |
0 |
0.21 |
| Anticoagulation Therapy |
0 |
0.15 |
| Biomedical Technology |
0 |
0.15 |
| Brain |
0 |
0.15 |
| Edema |
0 |
0.15 |
| Europe |
0 |
0.15 |
| Fatigue |
0 |
0.15 |
| Food and Drug Administration (FDA) |
0 |
0.15 |
| Hemorrhage |
0 |
0.15 |
| Medical Oncology |
0 |
0.15 |
| Nail |
0 |
0.15 |
| Nausea |
0 |
0.15 |
| Pain |
0 |
0.15 |
| Paresthesia |
0 |
0.15 |
| Pruritus |
0 |
0.15 |
| Stomatitis |
0 |
0.15 |
| Tyrosine Kinase |
0 |
0.15 |
| Venous Thromboembolism (VTE) |
0 |
0.15 |
| Virginia |
0 |
0.15 |
| Xeroderma |
0 |
0.15 |
| Constipation |
0 |
0.11 |
| Diarrhea |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Pain Management |
0 |
0.11 |